Osaic Holdings’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54K | Buy |
+658
| New | +$2.54K | ﹤0.01% | 6412 |
|
|
2025
Q1 | – | Sell |
-638
| Closed | -$2.41K | – | 7245 |
|
|
2024
Q4 | $2.41K | Buy |
638
+423
| +197% | +$1.6K | ﹤0.01% | 6400 |
|
|
2024
Q3 | $696 | Buy |
+215
| New | +$696 | ﹤0.01% | 6740 |
|
|
2024
Q2 | – | Sell |
-389
| Closed | -$1.11K | – | 7178 |
|
|
2024
Q1 | $1.11K | Sell |
389
-2,761
| -88% | -$7.84K | ﹤0.01% | 6485 |
|
|
2023
Q4 | $46.4K | Sell |
3,150
-22,514
| -88% | -$331K | ﹤0.01% | 4947 |
|
|
2023
Q3 | $470K | Buy |
25,664
+22,142
| +629% | +$405K | ﹤0.01% | 3293 |
|
|
2023
Q2 | $76K | Buy |
3,522
+2,200
| +166% | +$47.5K | ﹤0.01% | 4655 |
|
|
2023
Q1 | $38.8K | Sell |
1,322
-53
| -4% | -$1.56K | ﹤0.01% | 5116 |
|
|
2022
Q4 | $51K | Sell |
1,375
-1,067
| -44% | -$39.6K | ﹤0.01% | 4909 |
|
|
2022
Q3 | $69K | Buy |
2,442
+492
| +25% | +$13.9K | ﹤0.01% | 4653 |
|
|
2022
Q2 | $37K | Buy |
1,950
+550
| +39% | +$10.4K | ﹤0.01% | 5166 |
|
|
2022
Q1 | $18K | Buy |
+1,400
| New | +$18K | ﹤0.01% | 5725 |
|